• /ylen/upload/images/2020/5/746f5bc1f9e441e1.jpeg
    No evidence mosquitoes can pass coronavirus: top expert

    There is no evidence so far that the coronavirus can be transmitted by mosquitoes, China's top respiratory expert, Zhong Nanshan, said on Monday during a video conference with staff members from the Confucius Institute and Chinese students studying abroad.

  • /ylen/upload/images/2020/4/c4bc28df43cfb1fe.jpg
    Obat Pneumonia Koroner Dibutuhkan untuk Bantu Pasien Corona

    JAKARTA - Penyebaran wabah virus Corona (Covid-19) di dunia masih belum mereda termasuk di Indonesia. Pemasalahannya sampai saat ini belum ada vaksin dan obat khusus untuk menyembuhkan pasien Covid-19.

  • /ylen/upload/images/2020/4/17ddb0c62a2336ae.jpg
    Lianhua Qingwen listada no esquema de diagnóstico e tratamento da pneumonia pelo novo coronavírus no Laos

    SHIJIAZHUANG, China, 23 de abril de 2020 /PRNewswire/ -- A Yiling Pharmaceutical (002603.SZ) anunciou que as cápsulas (grânulos) da Lianhua Qingwen foram adicionadas ao "Esquema de diagnóstico e tratamento da pneumonia pelo novo coronavírus no Laos" (Versão II do Estudo) como o quarto medicamento tradicional chinês para o tratamento da pneumonia por COVID-19 no Laos.

  • /ylen/upload/images/2020/4/e839a878fa766bf3.jpeg
    TCM medicine on way to Italy

    China has donated 100,000 boxes of Lianhua Qingwen — a compound of herbal medicine that has been proved effective for treating COVID-19 patients — to Italy to help treat its patients there, experts said.

    The traditional Chinese medicine, which is said to kill viruses and remove lung heat, is suitable for clinical treatment of COVID-19 patients with a serious fever and constipation, Zhang Boli, an academician of the Chinese Academy of Engineering and president of Tianjin University of TCM, said on Monday at a news conference held in Wuhan by the State Council Information Office.

  • /ylen/upload/images/2020/4/f7446f0eb7b78a8c.jpg
    Lianhua Qingwen capsule (granule) was approved as an additional indication of COVID-19

    SHIJIAZHUANG, China, April 15, 2020 /PRNewswire/ -- On April 14, 2020, Yiling Pharmaceutical announced that Yiling Pharmaceutical and its subsidiary Beijing Yiling Pharmaceutical had received the approval document of drug supplement application concerning the application for new indications of Lianhua Qingwen capsules and Lianhua Qingwen granules issued by State Drug Administration. Lianhua Qingwen capsule and Lianhua Qingwen granules were approved to add "functional indications" to the originally approved indications: "In the conventional treatment of novel coronavirus pneumonia, it can be used for a light, common type of fever, cough, and fatigue", "Usage and dosage" increased "COVID-19 light, normal treatment for 7-10 days" and so on.